Overview
AIFF market data
Price History
AIFF price chart
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$1.60 Diluted earnings per share over the trailing twelve months.
- Beta
- 0.58 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- -565.4% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $0.62 – $3.63 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $18.2M · P/B 1.55 · P/S 11.49.
Company News
8-K filing — FIREFLY NEUROSCIENCE, INC. (AIFF)SEC EDGAR · Aug 7, 2026, 8:30 PM
Firefly Neuroscience (NASDAQ: AIFF) Reports 291% Increase in TMS Center Customer Brain Scan VolumesGlobenewswire Inc · Aug 5, 2026, 12:15 PM
Firefly Neuroscience Says TMS Center Customer Clinical Assessments Using Evoke Platform Rose 291% Year-Over-YearBenzinga · Aug 5, 2026, 11:47 AM
Firefly Neuroscience (NASDAQ: AIFF) and Next Health Launch Precision Cognitive Health Initiative as FDA Advisory Committee’s Recommendation Backs Broader Access to Key Neuroprotective PeptidesGlobenewswire Inc · Jul 28, 2026, 12:15 PM
Firefly Neuroscience And Next Health Partner To Launch Precision Cognitive Health Platform Integrating Firefly’s AI-Powered, FDA-Cleared EEG/ERP Brain Biomarker Technology With Personalized Cognitive Peptide ProtocolsBenzinga · Jul 28, 2026, 11:52 AM
Firefly Neuroscience Announces Identification Of Electrophysiological Biomarker For Post-Traumatic Stress Disorder Using Brain Scans Collected On FDA-510(k)-Cleared Evoke SystemBenzinga · Jun 2, 2026, 11:41 AM
Firefly Neuroscience Files Prospectus For Mixed Shelf Offering Of 22.5M SharesBenzinga · May 20, 2026, 12:15 PM